HLA with Oxford Nanopore Technologies

During this seminar, we first heard from James Brayer, Associate Director - Market Development, Oxford Nanopore Technologies Ltd., who gave an overview of the platform before we were joined by Dianne De Santis, Department of Clinical Immunology PathWest, Fiona Stanley Hospital Murdoch, who presented her latest research.